Vaccine formulations are described comprising physically separated, lyophilized antigens and adjuvant components, which may be in lyoparticle form, as well as methods of using and making such formulations. Reconstituted formulations are also described.

Vaccine formulations are described comprising physically separated, lyophilized antigens and adjuvant components, which may be in lyoparticle form, as well as methods of using and making such formulations. Reconstituted formulations are also described.

The present disclosure provides an aluminum phosphite-based complex with dual-peak thermal gravity decomposition characteristics and a preparation method and use thereof. A structural formula of the complex is as follows: ((HPO.sub.3).sub.3Al.sub.2).((H.sub.2PO.sub.3).sub.3Al).sub.x, wherein x is 0.01-0.5 and represents a molar ratio of (H.sub.2PO.sub.3).sub.3Al to (HPO.sub.3).sub.3Al.sub.2. The dual-peak thermal gravity decomposition characteristics are as follows: a first gravity peak temperature is 460-490° C., and a second gravity peak temperature is 550-580° C. The preparation method includes: uniformly mixing aluminum phosphite and aluminum hydrogen phosphite according to the ratio in the structural formula, and then performing stepwise heating at a rate of 5° C./min to raise the temperature of a mixture from the normal temperature to no more than 350° C. within 1-10 hours, so as to obtain the aluminum phosphite-based complex with the dual-peak thermal gravity decomposition characteristics. The complex may serve as or is configured to prepare a flame retardant or a flame-retardant synergist.

The present disclosure provides an aluminum phosphite-based complex with dual-peak thermal gravity decomposition characteristics and a preparation method and use thereof. A structural formula of the complex is as follows: ((HPO.sub.3).sub.3Al.sub.2).((H.sub.2PO.sub.3).sub.3Al).sub.x, wherein x is 0.01-0.5 and represents a molar ratio of (H.sub.2PO.sub.3).sub.3Al to (HPO.sub.3).sub.3Al.sub.2. The dual-peak thermal gravity decomposition characteristics are as follows: a first gravity peak temperature is 460-490° C., and a second gravity peak temperature is 550-580° C. The preparation method includes: uniformly mixing aluminum phosphite and aluminum hydrogen phosphite according to the ratio in the structural formula, and then performing stepwise heating at a rate of 5° C./min to raise the temperature of a mixture from the normal temperature to no more than 350° C. within 1-10 hours, so as to obtain the aluminum phosphite-based complex with the dual-peak thermal gravity decomposition characteristics. The complex may serve as or is configured to prepare a flame retardant or a flame-retardant synergist.

The present disclosure provides a method of producing an aluminum salt, comprising reacting activated aluminum metal (Al.sup.(0)) with an anion donor. Also provided are aluminum salts prepared by the disclosed methods.

The present disclosure provides a method of producing an aluminum salt, comprising reacting activated aluminum metal (Al.sup.(0)) with an anion donor. Also provided are aluminum salts prepared by the disclosed methods.

Provided is a negative electrode active material for a lithium secondary battery including: a silicon oxide (SiO.sub.x, 0<x≤2) composite including an alkali metal or alkaline earth metal-containing phosphate; and an aluminum-containing phosphate.

An aluminum nanoparticle adjuvant carrier system with stabilizing surface coatings that can efficiently deliver protein or nucleic acid antigen payloads to naive, resident APCs is disclosed.

Provided is a method for producing a high-purity aqueous lithium salt solution, the method allowing filtering aluminum phosphate in a short time. The method for producing a high-purity aqueous lithium salt solution includes: a step of adjusting the pH of a slurry containing a mixture of lithium phosphate and aluminum hydroxide obtained from a first aqueous lithium salt solution being a raw material to a range of 2 to 3 to obtain a precipitate of aluminum phosphate; a step of filtering off and removing the precipitate of aluminum phosphate to obtain a second aqueous lithium salt solution; and a step of purifying the second aqueous lithium salt solution to obtain a high-purity aqueous lithium salt solution.

Vaccine formulations are described comprising physically separated, lyophilized antigens and adjuvant components, which may be in lyoparticle form, as well as methods of using and making such formulations. Reconstituted formulations are also described.